Deva Rahayu Nurindah Kusuma Wardani; Adinugraha Amarullah; Dewi Rahmawati

doi:10.37036/jhmr.v2i2.459

Deva Rahayu Nurindah Kusuma Wardani Prodi S1 Farmasi, Fakultas Ilmu Kesehatan, Universitas Anwar Medika Sidoarjo, Indonesia
Adinugraha Amarullah Prodi S1 Farmasi, Fakultas Ilmu Kesehatan, Universitas Anwar Medika Sidoarjo, Indonesia
Dewi Rahmawati Prodi S1 Farmasi, Fakultas Ilmu Kesehatan, Universitas Anwar Medika Sidoarjo, Indonesia

DOI: https://doi.org/10.37036/jhmr.v2i2.459

Abstract

Background: Hypertension is a medical condition where there is an increase in blood pressure which can increase morbidity and mortality. Hypertension requires treatment for a long time and is relatively expensive.

Aims: This study aims to describe the cost of antihypertensive therapy and to analyze the most cost-minimizing treatment for JKN outpatients with hypertension at "X" Hospital, Surabaya City.

Methods: This research is a non-experimental research with quantitative methods and data collection is done retrospectively. The data analyzed is treatment therapy data for the period January - December 2022. The sample used was 96 patients. The cost measured is the direct medical cost of outpatients. The data was analyzed using the method of cost minimization analysis..

Results: The results showed that 58% of patients were female and 42% male with 1% of patients aged 21-40 years, 41-60 years of 25%, and ≥ 61 years of 74%. CMA results for Imidapril of Rp. 200.870,00, Bioprexum Rp. 348.683,33.00, Candesartan Cilexetil Rp. 103.840,23, Amlodipine Besilate Rp. 96.108,375, Nifedipine Rp. 254.538,00, Bisoprolol Rp. 155.045,00, and Carvedilol Rp. 148.955,00.

Conclusion: Amlodipine Besilate is the most cost minimized antihypertensive therapy compared to other antihypertensive therapies with an average direct cost of Rp. 96,108.375/patient.

References

Alifiar, I., & Idacahyati. (2018). Kajian Farmakoekonomi Penggunaan Obat Antihipertensi pada Pasien Hipertensi yang Dirawat di RSUD Kota Tasikmalaya. Jurnal Pharmascience, 05(02), 126–133. http://jps.unlam.ac.id/.
Aristoteles. (2018). Korelasi Umur dan Jenis Kelamin Dengan Penyakit Dengan Penyakit Hipertensi Di Emergency Center Unit Rumah Sakit Islam Siti Khadijah Palembang 2017. Indonesia Jurnal Perawat, 3(1), 9–16.
Astuti, V. W., & Amri, L. F. (2021). Prevalensi dan Analisis Faktor Risiko Hipertensi Pada Masyarakat di Wilayah Kerja Puskesmas Nanggalo Padang. 9(1), 1–9.
Khoiriyah, S. D., & Lestari, K. (2018). Kajian Farmakoekonomi Yang Mendasari Pemilihan Pengobatan di Indonesia. MPI (Media Pharmaceutica Indonesiana), 16(3), 134–143. https://doi.org/10.24123/mpi.v2i2.1391.
Putri, L. M., Rochmah, T. N., & Ernawaty, E. (2022). Catasthropic Health Expenditure Analysis Based on Cataracts Severity at Public & Private Hospital in Surabaya. Journal of Health Management Research, 1(1), 20–25.
utri, L. M., Sulistyana, C. S., Mamesah, M. M., & Iswati, I. (2022). Edukasi Pemberian Ekstrak Zingiber Afficine (Jahe Merah) Untuk Mengontrol Tekanan Darah Pada Penderita Hipertensi. PROSIDING SEMINAR NASIONAL PENGABDIAN KEPADA MASYARAKAT UNIVERSITAS NAHDLATUL ULAMA SURABAYA, 2(1), 72–83.
Putri, L. M., Kurniawan, A., Mamesah, M. M., & Rochmah, T. N. (2023). Analisis Kerugian Produktivitas Pasien Katarak Di Rumah Sakit Swasta Di Surabaya. MAINTEKKES: The Journal of Management Information and Health Technology, 1(1), 7–11.
Putri, L. M., Mamesah, M. M., Iswati, I., & Sulistyana, C. S. (2023). Faktor Risiko Hipertensi Pada Masyarakat Usia Dewasa & Lansia Di Tambaksari Surabaya. Journal of Health Management Research, 2(1), 1–6.
Riannur, T. (2021). Analisis Biaya Minimal Candesartan Dibandingkan Amlodipin Pada Pasien Hipertensi Rawat Jalan Di Rs “X” Kota Samarinda. Prosiding Sekolah Tinggi Ilmu Kesehatan, 94–103.
Sari, O. M. (2020). Studi Penggunaan Obat Golongan Beta-Blocker Pada Pasien Rawat Inap Rumah Sakit Ansari Saleh Banjarmasin. Jurnal Farmasi Udayana, 123. https://doi.org/10.24843/jfu.2020.v09.i02.p07.
Syuhada. (2021). Gambaran Penggunaan Obat Antihipertensi Lini Pertama di Apotek Rawat Jalan Rumah Sakit “X” Tarakan Tahun 2019. Journal Borneo, 1(1), 11–18.
Tiwaskar, M., Langote, A., Kashyap, R., & Toppo, A. (2018). Amlodipine in the era of new generation calcium channel blockers. Journal of Association of Physicians of India, 66(March), 59–64.
Xu, X., Wang, B., Ren, C., Hu, J., Greenberg, D. A., Chen, T., Xie, L., & Jin, K. (2017). Age-related impairment of vascular structure and functions. Aging and Disease, 8(5), 590–610. https://doi.org/10.14336/AD.2017.0430
Yulanda, G., & Lisiswanti, R. (2017). Penatalaksanaan Hipertensi Primer. Jurnal Majority, 6(1), 25–33.
Yunus, M. (2021). Hubungan Usia dan Jenis Kelamin Dengan Kejadian Hipertensi di Puskesmas Haji Pemanggilan Kecamatan Anak Tuha Kab. Lampung Tengah. Jurnal Ilmu Kedokteran Dan Kesehatan, 8(3), 229–239.
Zulfah, M. (2019). Analisis Efektivitas Biaya Kombinasi Obat Antihipertensi Pada Pasien Rawat Inap di RSUD Dr. Soekardjo Tasikmalaya. Journal of Pharmacopolium, 2(1), 53–62. https://doi.org/10.36465/jop.v2i1.472.

Cost Minimization Analysis Pasien JKN Rawat Jalan Penyakit Hipertensi di RS “X” Kota Surabaya

Abstract

References

Keywords